Selective Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$742K Buy
1,710
+102
+6% +$40.7K 0.17% 60
2026
Q2
$589K Buy
+1,608
New +$550K 0.15% 69
2022
Q4
– Sell
-85
Closed -$19K – 151
2022
Q3
$19K Buy
85
+15
+21% +$3.64K 0.01% 427
2022
Q2
$17K Hold
70
– – 0.01% 486
2022
Q1
$17K Sell
70
-750
-91% -$172K 0.01% 462
2021
Q4
$184K Hold
820
– – 0.08% 129
2021
Q3
$174K Buy
820
+750
+1,071% +$173K 0.09% 121
2021
Q2
$17K Buy
+70
New +$17.2K 0.01% 290

Other funds holding AMGN

Selective Wealth Management's AMGN Position: Q3 2026 in Review

Selective Wealth Management increased its Amgen (AMGN) stake by 6.3% in Q3 2026, buying an estimated $40.7K and bringing the position to 1,710 shares worth $742K. The position accounts for 0.17% of the portfolio, ranked #60.

Selective Wealth Management first reported a position in AMGN in Q2 2021 and has held it in 8 quarters since. 1,418 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Selective Wealth Management held 1,710 shares of Amgen worth $742K as of Q3 2026.
  • Selective Wealth Management bought 102 Amgen shares in Q3 2026, an estimated $40.7K.
  • Amgen made up 0.17% of Selective Wealth Management's portfolio in Q3 2026, its #60 holding.
  • Selective Wealth Management first reported a position in Amgen in Q2 2021 and has held it in 8 quarters since.
  • 1,418 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Selective Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.